Interstitial lung diseases in children

Presse Med. 2020 Jun;49(2):103909. doi: 10.1016/j.lpm.2019.06.007. Epub 2020 Jun 18.

Abstract

Interstitial lung disease (ILD) in children (chILD) is a heterogeneous group of rare respiratory disorders that are mostly chronic and associated with high morbidity and mortality. The pathogenesis of the various chILD is complex and the diseases share common features of inflammatory and fibrotic changes of the lung parenchyma that impair gas exchanges. The etiologies of chILD are numerous. In this review, we chose to classify them as ILD related to exposure/environment insults, ILD related to systemic and immunological diseases, ILD related to primary lung parenchyma dysfunctions and ILD specific to infancy. A growing part of the etiologic spectrum of chILD is being attributed to molecular defects. Currently, the main genetic mutations associated with chILD are identified in the surfactant genes SFTPA1, SFTPA2, SFTPB, SFTPC, ABCA3 and NKX2-1. Other genetic contributors include mutations in MARS, CSF2RA and CSF2RB in pulmonary alveolar proteinosis, and mutations in TMEM173 and COPA in specific auto-inflammatory forms of chILD. However, only few genotype-phenotype correlations could be identified so far. Herein, information is provided about the clinical presentation and the diagnosis approach of chILD. Despite improvements in patient management, the therapeutic strategies are still relying mostly on corticosteroids although specific therapies are emerging. Larger longitudinal cohorts of patients are being gathered through ongoing international collaborations to improve disease knowledge and targeted therapies. Thus, it is expected that children with ILD will be able to reach the adulthood transition in a better condition.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Child
  • Chronic Disease
  • Connective Tissue Diseases / complications
  • Connective Tissue Diseases / diagnosis
  • Environmental Exposure / adverse effects
  • Gene-Environment Interaction
  • Genotype
  • Humans
  • Immune System Diseases / complications
  • Infant
  • Infant, Newborn
  • Lung Diseases, Interstitial / classification
  • Lung Diseases, Interstitial / diagnosis*
  • Lung Diseases, Interstitial / drug therapy
  • Lung Diseases, Interstitial / etiology*
  • Phenotype
  • Pulmonary Alveolar Proteinosis / genetics
  • Respiration Disorders / complications
  • Respiratory System / pathology
  • Steroids / therapeutic use

Substances

  • Steroids